| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 01/02/2003 | EP1268787A2 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 01/02/2003 | EP1268783A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 01/02/2003 | EP1268771A1 Human gata-5 transcription factor |
| 01/02/2003 | EP1268760A1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments |
| 01/02/2003 | EP1268555A2 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 01/02/2003 | EP1268550A2 Human fap-alpha-specific antibodies |
| 01/02/2003 | EP1268530A1 Hepatitis b core antigen fusion proteins |
| 01/02/2003 | EP1268514A2 Methods for purifying highly anionic proteins |
| 01/02/2003 | EP1267940A1 Compounds for targeting |
| 01/02/2003 | EP1267925A1 Treatment of fungal infection with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies |
| 01/02/2003 | EP1267909A1 Methods of blocking tissue destruction by autoreactive t cells |
| 01/02/2003 | EP0885244B1 Peptide immunogens for vaccination against and treatment of allergy |
| 01/02/2003 | EP0771216B9 Methods and compositions for the specific coagulation of tumoral vasculature |
| 01/01/2003 | CN1388136A Double-specificity antibody resisting human ovary cancer and human CD3 |
| 01/01/2003 | CN1388131A Serial medicine carriers, tyrosine hydrozylase fusion protein as new carrier and its prepn |
| 01/01/2003 | CN1097468C Products containing G-CSF and TNF binding protein |
| 12/31/2002 | US6500941 Secreted by human breast cancer mda-mb-175 cells, leads to the formation of a constitutive active receptor complex and stimulates these cells in an autocrine manner |
| 12/31/2002 | US6500931 Portion of a complementarity determining region (cdr) derived from a non-human antibody with remaining portions human in origin; use in immunotherapy or as immunotoxins |
| 12/31/2002 | US6500924 Package for using antagonists of the vitronectin receptor alpha-v beta3 comprising a metalloproteinase polypeptide of given amino acid sequence; treating arthritis, rheumatoid arthritis, retinopathy and tumors |
| 12/31/2002 | US6500672 A competitive assay for binding activity to recombinant hepatocyte nuclear factor-4 receptors, a chimeric receptor comprising the ligand binding domain of a hnf-4 receptor and dna binding domain of another receptor |
| 12/31/2002 | US6500641 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, |
| 12/31/2002 | US6500636 Chimeric pre-activated transcription factors |
| 12/31/2002 | US6500431 Inhibitors of angiogenesis and tumor growth |
| 12/27/2002 | WO2002103016A2 Human tachykinin-related splice variants and compositions thereof |
| 12/27/2002 | WO2002103002A2 Gene associated with leishmania parasite virulence |
| 12/27/2002 | WO2002102839A2 Novel g-protein coupled receptors and dna sequences thereof |
| 12/27/2002 | WO2002102836A2 Moraxella (branhamella) catarrhalis antigens |
| 12/27/2002 | WO2002102320A2 Fce fusion proteins for treatment of allergy and asthma |
| 12/27/2002 | WO2002102299A2 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 12/27/2002 | WO2002095036A3 A novel intein and uses thereof |
| 12/27/2002 | WO2002070662A3 Three hybrid assay system |
| 12/27/2002 | WO2002008257A3 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof |
| 12/27/2002 | WO2002004514A8 Compositions and methods for the therapy and diagnosis of lung cancer |
| 12/27/2002 | WO2001096390A3 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/27/2002 | WO2001085937A3 Regulator of g protein signalling (rgs8) |
| 12/27/2002 | WO2000052184A9 Anti-neoplastic compositions and uses thereof |
| 12/27/2002 | CA2455387A1 Fce fusion proteins for treatment of allergy and asthma |
| 12/27/2002 | CA2455254A1 Moraxella (branhamella) catarrhalis antigens |
| 12/27/2002 | CA2445261A1 Human tachykinin-related splice variants and compositions thereof |
| 12/26/2002 | US20020198166 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 12/26/2002 | US20020197712 Polypeptide for use as tools in analyzing enzymatic gene expression |
| 12/26/2002 | US20020197667 Polypeptide for use in the treatment of thrombosis and sepsis |
| 12/25/2002 | CN1387575A Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 12/25/2002 | CN1387571A Mammalian cytokines, related reagents and methods |
| 12/25/2002 | CN1387539A Human monoclonal antibodies to prostate specific membrane antigen |
| 12/25/2002 | CN1387536A T2R-novel family of taste receptors |
| 12/24/2002 | US6498233 Nucleic acid transfer system |
| 12/24/2002 | US6498020 Fusion proteins comprising coiled-coil structures derived of bovine IF1 ATPase inhibitor protein |
| 12/24/2002 | US6497881 Complex comprising streptavidin-protein a fusion protein having antibody and biotin binding sites, bound antibody specific for cell surface protein, which undergoes endocytosis after binding, bound biotinylated toxin, expressed in cell |
| 12/24/2002 | CA2087261C Purification directed cloning of peptides |
| 12/24/2002 | CA2086264C Surface complexed lymphotoxin |
| 12/24/2002 | CA2070182C Chimeric immunoglobulin for cd4 receptors |
| 12/19/2002 | WO2002101069A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 12/19/2002 | WO2002101026A2 Methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms |
| 12/19/2002 | WO2002100348A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 12/19/2002 | WO2002085937A3 Inflammation-specific peptides and the uses thereof |
| 12/19/2002 | WO2002070565A3 High-affinity antagonists of elr-cxc chemokines |
| 12/19/2002 | WO2002066603A3 Chemically defined medium for cultured mammalian cells |
| 12/19/2002 | WO2002008287A3 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 12/19/2002 | WO2001068859A9 Il-17 receptor like molecules and uses thereof |
| 12/19/2002 | US20020193571 Wsx receptor agonist antibodies |
| 12/19/2002 | US20020193570 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 12/19/2002 | US20020192824 Viral vectors having chimeric envelope proteins containing the IgG-binding domain of protein A |
| 12/19/2002 | US20020192789 Novel enterokinase cleavage sequences |
| 12/19/2002 | US20020192758 C3b/C4b complement receptor-like molecules and uses thereof |
| 12/19/2002 | US20020192729 Apoptosis protein for use in the diagnosis and treatment of cell proliferative disorders |
| 12/19/2002 | US20020192721 Modular molecular clasps and uses thereof |
| 12/19/2002 | US20020192686 Recovery of cells expressing preferential phenotypes; obtain cells, store phenotypic data, monitor phenotypic adjustments in cells, recover and classify phenotypes of interest |
| 12/19/2002 | US20020192643 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders |
| 12/19/2002 | US20020192639 HCV antigen/antibody combination assay |
| 12/19/2002 | US20020192237 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis, and bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions |
| 12/19/2002 | US20020192232 Methods and compositions for impairing multiplication of HIV-1 |
| 12/19/2002 | US20020192230 Therapeutic formulations using heat shock/stress protein-peptide complexes |
| 12/19/2002 | CA2450285A1 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 12/19/2002 | CA2449602A1 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 12/18/2002 | EP1266014A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 12/18/2002 | EP1266012A2 Proteases |
| 12/18/2002 | EP1266008A2 Acute neuronal induced calcium binding protein type 1 ligand |
| 12/18/2002 | EP1266007A1 Human survivin interacting protein 1 (sip-1) |
| 12/18/2002 | EP1266002A2 Il-17 receptor like molecules and uses thereof |
| 12/18/2002 | EP1266000A1 Chordin-like-2 molecules and uses thereof |
| 12/18/2002 | EP1265999A2 Human schizophrenia gene |
| 12/18/2002 | EP1265990A2 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 12/18/2002 | EP1265926A1 Melanin concentrating hormone receptor chimeric and fusion proteins |
| 12/18/2002 | EP1265924A2 Il-17 receptor like molecules and uses thereof |
| 12/18/2002 | EP0892811B1 Peptides with antiproliferative properties |
| 12/18/2002 | EP0662150B1 Maspin, a novel serpin with tumor suppressing activity |
| 12/18/2002 | EP0641385B1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 12/18/2002 | EP0630255B1 Mhc conjugates useful in ameliorating autoimmunity |
| 12/18/2002 | EP0521996B1 Catalytic antibody components |
| 12/18/2002 | CN1385533A Process for preparing recombinant human liver cell grouth factor |
| 12/18/2002 | CN1385531A Dilutus culex chymotrypsin gene |
| 12/17/2002 | US6495736 Compositions and methods for increasing bone mineralization |
| 12/17/2002 | US6495666 Polypeptide composing human chimeric antibody |
| 12/17/2002 | US6495526 Inhibitors of cell-cycle progression and uses related thereto |
| 12/17/2002 | US6495347 Determining if fusion protein stimulates a th1-like response in cell sample; fusion proteins and conjugates that contain at least a portion of a heat shock protein; response detected by measuring interferon (ifn)-gamma produced by the cell sample |
| 12/17/2002 | US6495346 Do not react with foreign partners; amino acids inserted into proteins which naturally form dimers, mutated proteins only form complexes with themselves (homodimers) or with the mutated partner (heterodimers), not with nonmutated starting |
| 12/17/2002 | US6495136 Proteases having modified amino acid sequences conjugated to addition moieties |
| 12/17/2002 | CA2080260C Monoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereof |
| 12/17/2002 | CA1341411C Method for producing fv fragments in eukaryotic cells |